Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.062 | 0.7 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.12 | 0.7 |